0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liver Disease Drug"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Chronic Liver Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Liver Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Non Alcoholic Fatty Liver Disease (NAFLD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Liver Diseases Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Liver Diseases Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 125 Pages
  • Global
From
EUR$4,750USDGBP
Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 114 Pages
  • Global
From
EUR$4,750USDGBP
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • December 2022
  • 566 Pages
  • Global
From
EUR$2,500USDGBP
US Nonalcoholic Fatty Liver Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Nonalcoholic Fatty Liver Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
EUR$1,940USDGBP
Global Nonalcoholic Fatty Liver Disease Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Nonalcoholic Fatty Liver Disease Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
EUR$990USDGBP
Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 184 Pages
  • Global
From
EUR$2,500USDGBP
Liver Disease Diagnostics Market By End User, By Diagnosis Technique, By Region, Industry Analysis and Forecast, 2020 - 2026 - Product Thumbnail Image

Liver Disease Diagnostics Market By End User, By Diagnosis Technique, By Region, Industry Analysis and Forecast, 2020 - 2026

  • Report
  • June 2020
  • 173 Pages
  • Global
From
EUR$3,600USDGBP
Fatty Liver Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Fatty Liver Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 102 Pages
  • Global
From
EUR$3,944USDGBP
Non Alcoholic Fatty Liver Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 117 Pages
  • Global
From
EUR$3,944USDGBP
Liver Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Liver Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 107 Pages
  • Global
From
EUR$3,944USDGBP
Liver Diseases Treatment Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Thumbnail Image

Liver Diseases Treatment Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • December 2024
  • 150 Pages
  • Global
From
EUR$3,950USDGBP
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 93 Pages
  • Global
From
EUR$2,000USDGBP
Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 49 Pages
  • Global
From
EUR$2,000USDGBP
Liver Disease Treatment Market by Treatment Type and Disease Type: Global Opportunity Analysis and Industry Forecast, 2021-2030 - Product Thumbnail Image

Liver Disease Treatment Market by Treatment Type and Disease Type: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • Report
  • December 2021
  • 254 Pages
  • Global
From
EUR$3,712USDGBP
Loading Indicator

The Liver Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat a variety of liver diseases, including hepatitis, cirrhosis, and fatty liver disease. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Commonly used drugs include antivirals, immunosuppressants, and antifibrotics. In addition, some drugs are used to reduce the risk of liver cancer. The Liver Disease Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Pfizer, and Novartis. Other companies include Bristol-Myers Squibb, AstraZeneca, and Roche. Show Less Read more